Megace

In the US, Megace (megestrol systemic) is a member of the following drug classes: hormones/antineoplastics, progestins and is used to treat Abnormal Uterine Bleeding, AIDS Related Wasting, Anorexia, Breast Cancer - Palliative, Cachexia, Endometrial Cancer, Endometrial Hyperplasia, Hot Flashes and Weight Loss.

US matches:

• Megace ES


• Megace ES Suspension


• Megace Suspension


• Megace


• Megace Oral Suspension

UK matches:

• Megace 160 mg Tablets (SPC)

Ingredient matches for Megace

Megestrol

Megestrol is reported as an ingredient of Megace in the following countries:

• Colombia


• Peru


• Tunisia

Megestrol 17α-acetate (a derivative of Megestrol) is reported as an ingredient of Megace in the following countries:

• Algeria


• Australia


• Belgium


• Bosnia & Herzegowina


• Canada


• Chad


• Chile


• China


• Cote D'ivoire


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Estonia


• Finland


• France


• Gabon


• Greece


• Guinea


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Italy


• Latvia


• Lithuania


• Luxembourg


• Mali


• Mauritius


• Netherlands


• New Zealand


• Niger


• Norway


• Philippines


• Poland


• Portugal


• Romania


• Senegal


• Serbia


• Singapore


• Slovakia


• Slovenia


• Sweden


• Taiwan


• Thailand


• Togo


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.